Wegovy vs Zepbound for Women Over 50: A Doctor's Guide to Choosing

If you're a woman over 50 considering a GLP-1 medication for weight loss, you've probably heard about Wegovy and Zepbound. These two medications are leading options, but they work differently and may have different effects as your body changes with age. Understanding how each medication works and what to expect can help you have a more informed conversation with your doctor about which option might be right for you.

Understanding GLP-1 Medications and How They Work

Both Wegovy and Zepbound belong to a class of medications that mimic hormones your body naturally produces to regulate blood sugar and appetite. But there's an important difference in how they work.

Wegovy contains semaglutide, which mimics a single hormone called GLP-1. This hormone signals to your brain that you're full, slows how quickly food leaves your stomach, and helps your pancreas release insulin when needed.

Zepbound contains tirzepatide, which works on two hormone pathways instead of one. It mimics both GLP-1 and another hormone called GIP. This dual action may explain why some studies show slightly greater weight loss with Zepbound compared to Wegovy.

Weight Loss Results: What the Research Shows

Clinical trials provide helpful benchmarks, though individual results vary widely based on diet, exercise, and metabolism.

In studies, people taking Wegovy lost an average of 15% of their body weight over 68 weeks. For someone weighing 200 pounds, that's approximately 30 pounds.

Zepbound studies showed an average weight loss of 18-22% over a similar timeframe, depending on the dose. For that same 200-pound person, that could mean 36-44 pounds.

What This Means for Women Over 50

After menopause, hormonal changes often make weight loss more challenging. Declining estrogen levels can shift where your body stores fat, increase appetite, and slow metabolism. Both medications can help overcome these obstacles, but they don't eliminate them entirely.

Women over 50 in clinical trials generally saw results comparable to younger participants, though some studies suggest the rate of weight loss may be slightly slower. What matters more than age is consistency with the medication, realistic expectations, and sustainable lifestyle changes.

Side Effects and How Your Body May Respond

Both medications share similar side effects because they work on the digestive system. The most common issues include nausea, diarrhea, constipation, vomiting, and stomach discomfort.

These side effects are typically strongest when you first start the medication or increase your dose. They often improve over time as your body adjusts.

Considerations Specific to Women Over 50

As we age, our digestive systems may become more sensitive. Some women over 50 report that nausea feels more intense or takes longer to subside. Constipation can also be more problematic, especially if you're already dealing with slower digestion.

Staying well-hydrated, eating smaller meals, and increasing fiber gradually can help manage these effects. If you're on other medications for conditions like high blood pressure or thyroid issues, talk with your doctor about potential interactions.

Dosing and How Treatment Progresses

Both Wegovy and Zepbound are given as once-weekly injections that you administer yourself using a pre-filled pen.

Wegovy starts at 0.25 mg weekly and gradually increases over several months to a maintenance dose of 2.4 mg. Zepbound starts at 2.5 mg weekly and can increase to 5 mg, 10 mg, or 15 mg depending on your response and tolerance.

The gradual increase helps your body adjust and minimizes side effects. Your doctor will monitor your progress and adjust the pace based on how you're tolerating the medication.

Cost Considerations and Insurance Coverage

Both medications carry similar list prices of around $1,000-$1,300 per month without insurance. Coverage varies significantly depending on your insurance plan.

Some insurance plans cover these medications for weight loss, while others only cover them if you have type 2 diabetes. Medicare typically doesn't cover weight loss medications, which affects many women over 65.

If cost is a barrier, ask your doctor about compounded versions of semaglutide and tirzepatide, which contain the same active ingredients but are prepared by specialized pharmacies at a lower cost.

Which Medication Might Be Right for You?

There's no universal answer, but here are some factors to discuss with your doctor.

Consider Wegovy if you prefer a medication with a longer track record, as semaglutide has been studied more extensively. It may also be a good starting point if you're concerned about side effects, as some people find it slightly gentler on the stomach.

Consider Zepbound if maximizing weight loss is your primary goal, as the dual-action mechanism may offer an edge. Some patients also report feeling more satisfied with less food on tirzepatide.

Beyond the Medication Itself

The best medication is the one you can access consistently and tolerate well. If your insurance covers one but not the other, that may make your decision easier. If you start one and don't see results or experience difficult side effects, switching to the other is often an option.

Remember that these medications work best alongside nutrition changes and increased physical activity. They're powerful tools, but not magic solutions.

From the Ozari Care Team

Women over 50 often see excellent results with GLP-1 medications, but patience is key. We recommend taking progress photos and measurements in addition to watching the scale, as body composition changes can be significant even when weight loss slows. Don't hesitate to communicate openly with your provider about side effects—adjusting your dose timeline can make the journey much more comfortable.

At Ozari Health we offer compounded Semaglutide and Tirzepatide as low as $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026